COVID-19 Outpatient Treatment
- If you have a positive COVID-19 test and develop severe symptoms such not being able to breathe, chest pain and/or low oxygen levels, then you should seek immediate evaluation and treatment at the nearest emergency department.
- The oral antiviral medications Paxlovid and Molnupiravir have been authorized, but not fully approved, by the Food and Drug Administration (FDA) for outpatient treatment of certain high risk adults diagnosed COVID-19 within the first 5 days of symptoms. These medications, once available, will need to be prescribed by a licensed healthcare provider. If you test positive for COVID-19 and do not have severe symptoms, speak to your healthcare provider to see if/how you may be eligible to receive these medications. Be aware that these medications will be available in extremely limited quantities and at only a few federally-designated pharmacies in our area beginning January 2022. A prescription is necessary, but is not a guarantee that you will be able to get the medication.
- Once the Omicron variant becomes the dominant strain in our area, then the availability of effective monoclonal antibody infusions to treat mild disease will become very limited, as most of the current available supply is not effective against the Omicron strain. If you test positive for COVID-19 and have mild symptoms, contact your healthcare provider to see if this treatment is available and right for you.
- If you are COVID-19 negative, unexposed, and immunocompromised due to an illness or medication (for example, organ transplant, hematologic malignancy, or advanced uncontrolled HIV infection), then speak to your healthcare provider to see if you are eligible and how to receive a newly FDA-authorized, but not approved medication, Evulsheld, for pre-exposure prevention of COVID-19.
Emergency Use Authorizations
Visit our coronavirus information page to learn more about COVID-19 testing locations, vaccines and more.